Rodger E. Tiedemann

Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

Jonathan J. Keats, Rafaël Fonseca, Marta Chesi et al. · Cancer Cell · 2007 · 980 citations · Full text

Hematological Malignancy, Medicine, Cancer Cell Biology +7

Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma

Chungyee Leung-Hagesteijn, Natalie Erdmann, Grace W.C. Cheung et al. · Cancer Cell · 2013 · 401 citations · Full text

Hematological Malignancy, Tumor Biology, Oncology +7

AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies

Marta Chesi, Davide F. Robbiani, Michaël Sébag et al. · Cancer Cell · 2008 · 379 citations · Full text

Hematological Malignancy, Tumor Biology, Oncology +10

Genetic aberrations and survival in plasma cell leukemia

Rodger E. Tiedemann, Natalia González-Paz, Robert A. Kyle et al. · Leukemia · 2008 · 340 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Genetics +3

Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma

Suzanne Trudel, Zhihua Li, Jennifer Rauw et al. · Blood · 2007 · 216 citations · Full text